Socio-economic burden of rare diseases: A systematic review of cost of illness evidence
作者： Aris Angelis , David Tordrup , Panos Kanavos
DOI: 10.1016/J.HEALTHPOL.2014.12.016
关键词:
摘要: … In the context of the BURQOL-RD project (“Social Economic Burden and Health-Related Quality of Life in patients with Rare Diseases in Europe”) we studied the evidence on direct and …
lse.ac.uk
core.ac.uk
elsevier.com
sci-hub.se 参考文章(94)
Craig M. McDonald, Richard T. Abresch, Gregory T. Carter, William M. Fowler, E Ralph Johnson, David D. Kilmer, Barbara J. Sigford, Duchenne Muscular Dystrophy American Journal of Physical Medicine & Rehabilitation. ,vol. 74, pp. S70- S92 ,(1995) , 10.1097/00002060-199509001-00003
Arego De, Koch Sj, Bowser B, Outpatient rehabilitation for chronic neuromuscular diseases. American journal of physical medicine. ,vol. 65, pp. 245- 257 ,(1986)
Michael Drummond, Cost-of-Illness Studies PharmacoEconomics. ,vol. 2, pp. 1- 4 ,(1992) , 10.2165/00019053-199202010-00001
Thomas Tencer, Howard S Friedman, Josephine Li-McLeod, Kathleen Johnson, None, Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection. Journal of Managed Care Pharmacy. ,vol. 13, pp. 790- 798 ,(2007) , 10.18553/JMCP.2007.13.9.790
Allaire Sh, Schaller Jg, Meenan Rf, Szer Is, DeNardo Bs, The economic impacts of juvenile rheumatoid arthritis. The Journal of Rheumatology. ,vol. 19, pp. 952- 955 ,(1992)
Gerry Oster, Daniel M Huse, Michael J Lacey, Meredith M Regan, Henry J Fuchs, Effects of Recombinant Human DNase Therapy on Healthcare use and Costs in Patients with Cystic Fibrosis Annals of Pharmacotherapy. ,vol. 29, pp. 459- 464 ,(1995) , 10.1177/106002809502900501
Daniela Eidt, Thomas Mittendorf, Thomas O. F. Wagner, Andreas Reimann, J.-Matthias Graf von der Schulenburg, Evaluation von Kosten der ambulanten Behandlung bei Mukoviszidose in Deutschland Medizinische Klinik. ,vol. 104, pp. 529- 535 ,(2009) , 10.1007/S00063-009-1112-9
Abdel R. Omran, The Epidemiologic Transition: A Theory of the Epidemiology of Population Change Bulletin of The World Health Organization. ,vol. 79, pp. 161- 170 ,(2001) , 10.1590/S0042-96862001000200012
Christoph T. H. Baltin, Christina Smaczny, Thomas O. Wagner, Medikamentöse Behandlung von Mukoviszidose – Kostenstruktur und Einsparpotenzial der ambulanten Behandlung Medizinische Klinik. ,vol. 105, pp. 887- 900 ,(2010) , 10.1007/S00063-010-1154-Z
Thomas A. Hodgson, Mark R. Meiners, Cost-of-illness methodology: a guide to current practices and procedures Milbank Quarterly. ,vol. 60, pp. 429- 462 ,(1982) , 10.2307/3349801